Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.39 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.39 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.39 |
| ▸ | GSR | P00390 | 1/20 | 0.38 |
| ▸ | NMT2 | O60551 | 1/20 | 0.38 |
| ▸ | NMT1 | P30419 | 1/20 | 0.38 |
| ▸ | ACE | P12821 | 1/20 | 0.38 |
| ▸ | FURIN | P09958 | 1/20 | 0.37 |
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30567409 | 0.96 | ACE (0.41) | DPP8DPP9DPP7GSRNMT2 | |
| SCHEMBL28453993 | 0.93 | GSR (0.44) | DPP8DPP9DPP7GSRNMT2 | |
| SCHEMBL28453999 | 0.93 | GSR (0.44) | DPP8DPP9DPP7GSRNMT2 | |
| SCHEMBL29551013 | 0.93 | NMT2 (0.43) | NMT2NMT1 | |
| SCHEMBL28382528 | 0.92 | NMT2 (0.45) | DPP8DPP9DPP7GSRNMT2 | |
| SCHEMBL28382531 | 0.92 | NMT2 (0.45) | DPP8DPP9DPP7GSRNMT2 | |
| SCHEMBL29366972 | 0.92 | GSR (0.41) | DPP8DPP9DPP7GSRACE | |
| SCHEMBL827833 | 0.92 | NMT2 (0.45) | DPP8DPP9DPP7GSRNMT2 | |
| SCHEMBL827832 | 0.92 | NMT2 (0.45) | DPP8DPP9DPP7GSRNMT2 | |
| SCHEMBL29404549 | 0.92 | ACE (0.46) | DPP8DPP9DPP7GSRACE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025064804-A1 | POLYMERIC BIOMATERIALS FOR TISSUE REGENERATION AND METHODS OF USE THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-03-27 | — | — | WO | disclosed |